PropertyValue
?:author
?:datePublished
  • 2016-06-21 (xsd:date)
?:headline
  • Marijuana Is Moving to Schedule 2 (en)
?:inLanguage
?:itemReviewed
?:mentions
?:reviewBody
  • In mid-June 2016, rumors began to circulate on social media claiming that the Drug Enforcement Agency (DEA) would effectively be legalizing marijuana by moving it from Schedule 1 classification (drugs with no currently accepted medical use in treatment in the United States) to Schedule 2 (drugs that have a currently accepted medical use in treatment in the United States), which would pot to be used and researched for medical purposes. A 18 June 2016 article published by the Santa Monica Observer included commentary from an anonymous source said to be a DEA lawyer in which the difference between Schedule 1 and Schedule 2 classifications was explained: The article stated that marijuana would be rescheduled alongside Percocet, Aderall [sic], Oxycontin, Hydrocodone and other drugs that are legal, even common, with a prescription as a Schedule 2 drug. It continued with speculation that California's medical marijuana industry would view the move as unwelcome competition: The item was popular among residesnts of states without flexible medical marijuana policies, as it suggested that the sale of weed lozenges at CVS was on the horizon, but remarks about the change being election year maneuvering bordered on conspiracy theory. And not everyone was convinced the anonymous source was credible — a post on the Daily Chronic blog expressed considerable skepticism of the assertion: That marijuana-centric outlet decried the swift circulation of the rumor-as-fact across social media and cannabis blogs: On 17 June 2016, business site Inc. addressed what such a change might mean for the fledgling cannabis industry, noting that marijuana's rescheduling would subject many businesses to a change in regulation and Food and Drug Administration (FDA) oversight: The Denver Post (based in Colorado, where marijuana is currently legal for recreational use) ran an editorial surmising that states with laws allowing for broader use of legal cannabis would suffer fiscal losses under a rescheduling of the substance: Claims that marijuana would move from Schedule 1 to Schedule 2 on 1 August 2016 initially excited folks in states without laws allowing for medical or recreational use of the substance, but the claims were made by an anonymous source to a small community newspaper. And in August 2016 the DEA dashed those hopes by announcing they had declined two rescheduling petitions: (en)
?:reviewRating
rdf:type
?:url